0001225208-19-003890.txt : 20190227
0001225208-19-003890.hdr.sgml : 20190227
20190227185452
ACCESSION NUMBER: 0001225208-19-003890
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190225
FILED AS OF DATE: 20190227
DATE AS OF CHANGE: 20190227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clyburn Frank
CENTRAL INDEX KEY: 0001763963
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 19639678
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
X0306
4
2019-02-25
0000310158
Merck & Co., Inc.
MRK
0001763963
Clyburn Frank
MERCK & CO., INC.
2000 GALLOPING HILL ROAD
KENILWORTH
NJ
07033
1
EVP, Chief Commercial Officer
Common Stock
2019-02-25
4
A
0
4017.0000
80.3800
A
66188.7250
D
Common Stock - 401(k) Plan
1411.7874
I
By 401(k)
Distrubtion of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/16. Performance shares were paid out at 126 percent of target awards. Includes dividends accured over the three-year performance period ending December 31, 2018.
Holdings include shares acquired in dividend reinvestment transactions.
Includes shares acquired and dividends earned through January 8, 2019, in the Merck U.S. Savings Plan, a 401(k) plan.
Faye C. Brown as Attorney-in-Fact for Frank Clyburn
2019-02-27